N/A
Completed N=132
Brief Behavioral Treatment for Insomnia in Cancer Survivors
Source: ClinicalTrials.gov NCT03810365 ↗Enrolled (actual)
132
Serious AEs
0.0%
Results posted
Nov 2023
Primary outcomePrimary: Insomnia Severity Index — 7.03; 9.26 score on a scale
Summary
The purpose is to determine whether brief behavioral treatment is effective for insomnia in cancer survivors.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Insomnia Severity Index |
7.03; 9.26 | — |
Eligibility Criteria
Inclusion Criteria
- > or = 4 weeks from surgery for cancer treatment; chemotherapy and/or radiation therapy; no wait for hormone therapy or targeted treatment for stage I, II, or III: breast, colorectal, prostate, lung cancer
- chronic insomnia
Exclusion Criteria
- Other preexisting sleep disorders except those with OSA stable on CPAP
- Unstable medical illnesses
Data sourced from ClinicalTrials.gov (NCT03810365). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.